Company |
Drug |
Indication |
Bristol-Myers Squibb Co. and Astrazeneca plc |
Farxiga |
Type 2 diabetes |
Glaxosmithkline plc |
Mekinist |
Unresectable melanoma or metastatic melanoma |
Merck & Co. Inc. |
Isentress |
HIV |
Nuvo Research Inc. |
Pennsaid |
Osteoarthritis of the knee |
Teva Pharmaceutical Industries Ltd. |
Copaxone |
New dose for multiple sclerosis |